Inmune Bio, Inc.
Public company- Headquarters
- BOCA RATON, Florida
- Industry
- Biotechnology
- Ticker
- INMB
- CIK
- 0001711754
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
2 appointments, 0 departures
Last event
Sep 14, 2026
Executive appointmentdirector appointed: R. Duane Clark II
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorR. Duane Clark II | Sep 14, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Executive appointment
director appointed: R. Duane Clark II
R. Duane Clark II was named director of Inmune Bio, Inc., effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 14, 2026Role: director
- Executive appointment
director appointed: James Sapirstein
James Sapirstein was named director of Inmune Bio, Inc., effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 14, 2026Role: director
Last verified Nov 8, 2026